ImmunoPrecise Antibodies Ltd. announced that it has appointed Lisa Helbling as Chief Financial Officer. Lisa Helbling brings over 30 years of experience in accounting, financing, and business development within the public markets and has a demonstrated ability to manage financial and operational challenges while governing a dynamic and growing business. Helbling previously served as the CFO at Anchor Ingredients, a specialty commodity company that provides end-to-end ingredient supply from farm origination, value added processing and distribution to human and pet food markets. In addition to sourcing commodities from ND and the U.S., the company imports products from 21 countries and exports products to 13 countries. Helbling also held the CFO position at TMI Hospitality from December 2011 - December 2017. TMI develops and manages select service and extended stay hotels. The portfolio included 189 hotels across 27 states under 18 nationally recognized brands. TMI employed approximately 4,700 employees, 220 employees in the Fargo corporate office. Prior to working at TMI, Helbling worked at Otter Tail Corporation, from February 2002 - December 2011, a publicly traded (OTTR) electric utility with diversified operations in manufacturing, construction, transportation, health services, and food ingredient processing.